BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Natco Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524816
ISIN Demat
INE987B01026
Book Value (Rs)
477.507017
NSE Symbol
NATCOPHARM
Divident Yield %
0.6
Market Cap
(Rs In Cr.)
14,796
P/E (TTM)
16.59
EPS (TTM)
49.8
Face Value
(Rs)
2
Back
Natco Pharma announces conclusion of USFDA inspection of its Visakhapatnam unit
22-Aug-26   Hrs IST

Natco Pharma announced conclusion of US FDA Inspection at its Visakhapatnam, Andhra Pradesh, Finished Dosage Formulations (FDF) Unit. The inspection was conducted from 17 August to 21 August 2026.

Upon conclusion of the inspection, the Company has been issued a Form 483 with 4 (Four) observations.

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)